Immunocytochemistry staining enables the distinction of atypical meningiomas from gliomas, neurogenic tumors, mesenchymal tumors, and some metastatic tumors with epithelial membrane antigen (EMA), with vimentin being the preferred diagnostic marker for meningiomas [43,44]. The gene discussed is MUC1; the disease is central nervous system cancer.